Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 3
2007 2
2008 1
2009 2
2010 2
2011 1
2012 2
2013 1
2014 2
2015 6
2016 9
2017 4
2018 5
2019 6
2020 10
2021 7
2022 8
2023 9
2024 10
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Applications of SGLT2 inhibitors beyond glycaemic control.
O'Hara DV, Lam CSP, McMurray JJV, Yi TW, Hocking S, Dawson J, Raichand S, Januszewski AS, Jardine MJ. O'Hara DV, et al. Among authors: januszewski as. Nat Rev Nephrol. 2024 Aug;20(8):513-529. doi: 10.1038/s41581-024-00836-y. Epub 2024 Apr 26. Nat Rev Nephrol. 2024. PMID: 38671190 Review.
Diabetes, metabolic disease, and telomere length.
Cheng F, Carroll L, Joglekar MV, Januszewski AS, Wong KK, Hardikar AA, Jenkins AJ, Ma RCW. Cheng F, et al. Among authors: januszewski as. Lancet Diabetes Endocrinol. 2021 Feb;9(2):117-126. doi: 10.1016/S2213-8587(20)30365-X. Epub 2020 Nov 26. Lancet Diabetes Endocrinol. 2021. PMID: 33248477 Review.
A microRNA-based dynamic risk score for type 1 diabetes.
Joglekar MV, Wong WKM, Kunte PS, Hardikar HP, Kulkarni RA, Ahmed I, Farr RJ, Pham NHT, Coles M, Kaur S, Maynard CL, Hayward R, Thorat V, Pant A, Akil AA, Donaghue KC, Jenkins AJ, Piya MK, Craig ME, Hague WM, Yajnik CS, Chan JCN, Shapiro AMJ, Davis EA, Jones TW, Gitelman SE, Ma RCW, Pociot F, Hardikar AA; PREDICT T1D Study Group. Joglekar MV, et al. Nat Med. 2025 Aug;31(8):2622-2631. doi: 10.1038/s41591-025-03730-7. Epub 2025 Jun 5. Nat Med. 2025. PMID: 40473952 Free PMC article.
Biomarkers in Diabetic Retinopathy.
Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS. Jenkins AJ, et al. Among authors: januszewski as. Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159. Epub 2015 Aug 10. Rev Diabet Stud. 2015. PMID: 26676667 Free PMC article. Review.
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial.
Wittert GA, Robledo KP, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Bracken K, Allan CA, Jesudason D, Jenkins A, Januszewski AS, Grossmann M. Wittert GA, et al. Among authors: januszewski as. J Clin Endocrinol Metab. 2025 Jun 17;110(7):e2157-e2170. doi: 10.1210/clinem/dgaf060. J Clin Endocrinol Metab. 2025. PMID: 39928571 Free PMC article. Clinical Trial.
Increased intracellular miR-142 in adults with Type 1 diabetes.
Huang L, Januszewski AS, Takahashi Y, O'Neal DN, Ma JX, Jenkins AJ. Huang L, et al. Among authors: januszewski as. J Diabetes Complications. 2023 Oct;37(10):108597. doi: 10.1016/j.jdiacomp.2023.108597. Epub 2023 Aug 25. J Diabetes Complications. 2023. PMID: 37659140 Free PMC article.
Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy.
Ong KL, Januszewski AS, Francis H, O'Connell RL, Mangani A, Li L, Colman PG, Sullivan DR, Scott RS, Jenkins AJ, Keech AC; FIELD Study Investigators. Ong KL, et al. Among authors: januszewski as. Diabetes Res Clin Pract. 2025 Apr;222:112080. doi: 10.1016/j.diabres.2025.112080. Epub 2025 Mar 11. Diabetes Res Clin Pract. 2025. PMID: 40081501 Free article. Clinical Trial.
89 results